The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs

API Maker Gets Form 483 for Minimal Materials Testing

Nov. 29, 2013
A A
Avatar Corporation was chided by the FDA for not always testing active pharmaceutical ingredients (API) against USP monographs. FDA investigators found the poor testing record during a July inspection of the company’s University Park, Ill., facility.
Drug GMP Report